Zurich Cantonal Bank
MDXG icon

Zurich Cantonal Bank’s MiMedx Group MDXG Stock Holding History

Zurich Cantonal Bank’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,713
Closed -$269K – 3113
2025
Q4 		$269K Buy
+39,713
New +$278K ﹤0.01% 2113

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Zurich Cantonal Bank's MDXG Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 39,713 shares — an estimated $157K sold.

Zurich Cantonal Bank first reported a position in MDXG in Q3 2015 and held it in 32 quarters. The position peaked at $323K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Zurich Cantonal Bank reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • Zurich Cantonal Bank sold 39,713 MiMedx Group shares in Q2 2026, an estimated $157K.
  • Zurich Cantonal Bank first reported a position in MiMedx Group in Q3 2015 and held it in 32 quarters.
  • Zurich Cantonal Bank's MiMedx Group position peaked at $323K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.